Overview

NAC Effect on Infertile Women With Endometrioma

Status:
Recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
Oxidative stress has been investigated as a key factor in the pathogenesis and progression of endometrioma. High follicular fluid ROS levels and serum can be related to negative IVF/ICSI outcomes in infertile women with endometrioma. Therefore, the use of antioxidants such as N-acetyl cysteine (NAC) may be reduced complications of endometrioma. To study this hypothesis, we designed a double-blind, randomized clinical trial study that aimed to determine the effect of N-acetyl cysteine (NAC) on stress oxidative factors and pregnancy outcomes in IVF/ICSI cycles in endometrioma patients.
Phase:
Phase 3
Details
Lead Sponsor:
Royan Institute
Treatments:
Acetylcysteine
N-monoacetylcystine